Y
Yongyut Kongthanarat
Publications - 3
Citations - 207
Yongyut Kongthanarat is an academic researcher. The author has contributed to research in topics: Randomized controlled trial & Head and neck cancer. The author has an hindex of 3, co-authored 3 publications receiving 189 citations.
Papers
More filters
Journal ArticleDOI
Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial.
Vicharn Lorvidhaya,Imjai Chitapanarux,Supatra Sangruchi,Prasert Lertsanguansinchai,Yongyut Kongthanarat,Saipin Tangkaratt,Ekachai Visetsiri +6 more
TL;DR: Conurrent chemotherapy, mitomycin C, and 5-FU together with conventional RT showed an improved DFS rate when compared with conventionalRT alone in patients with locally advanced carcinoma of the cervix, and there were no increases in late side effects.
Journal ArticleDOI
Reduced recurrence of late hemorrhagic radiation cystitis by WF10 therapy in cervical cancer patients: A multicenter, randomized, two-arm, open-label trial
Vutisiri Veerasarn,Chonlakiet Khorprasert,Vicharn Lorvidhaya,Supatra Sangruchi,Thanatip Tantivatana,Ladawan Narkwong,Yongyut Kongthanarat,Imjai Chitapanarux,Chanawat Tesavibul,Apichart Panichevaluk,Sirisak Puribhat,Somphob Sangkittipaiboon,Lak Sookpreedee,Prasert Lertsanguansinchai,Pramook Phromratanapongse,Poonkiat Rungpoka,Supamitr Trithratipvikul,Bannakij Lojanapiwat,Sathit Ruangdilokrat,Pichai Ngampanprasert +19 more
TL;DR: WF10 therapy is a safe, non-invasive and convenient method in the management of late hemorrhagic radiation cystitis and has significantly reduced recurrence of objective hematuria, compared to standard treatment alone, during a one year follow up.
Journal Article
Effect of Amifostine to prevent radiotherapy-induced acute and late toxicity in head and neck cancer patients who had normal or mild impaired salivary gland function.
Vutisiri Veerasarn,Pramook Phromratanapongse,Nan Suntornpong,Vicharn Lorvidhaya,Vimol Sukthomya,Imjai Chitapanarux,Chanawat Tesavibul,Thiti Swangsilpa,Cholakiet Khorprasert,Kanjana Shotelersuk,Yongyut Kongthanarat,Apichart Panichevaluk,Sunanta Chiewvit,Pawana Pusuwan,Monreudee Aekmahachai,Samart Ratchadara,Sasitorn Sirilipoche,Yuttana Saengsuda +17 more
TL;DR: In this paper, the salivary gland function returned to normal at a rate of 36.3% in the Amifostine group versus 9.1% in a control group.